Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
In: British Journal of Pharmacology, Jg. 135 (2002), Heft 1, S. 103-112
Online
academicJournal
Zugriff:
I The efficacy of the free radical trapping agent NXY-059 in reducing the infarct volume following both transient and permanent focal ischaemia has been examined in rats. 2 In the transient ischaemia model, rats were subjected to a 2 h occlusion of the middle cerebral artery (MCA). Intravenous infusion of NXY-059 (1, 10 and 30 mg kg[sup -1] h) for 21.75 h starting 2.25 h after the occlusion, produced a dose-dependent decrease in both neurological impairment and the histologically measured infarct volume (a mean 59% decrease at 10 mg kg[sup -1] h). 3 In the permanent ischaemia model, animals were injected (s.c.) with a loading dose of NXY-059 of 32.5, 53.8 or 75.4 mg kg[sup -1] and osmotic minipumps were implanted which had been primed to deliver respectively 30, 50 or 70 mg kg[sup -1] h. When treatment was initiated 5 min after MCA occlusion there was a dose dependent protection of both cortical and sub-cortical tissue (cortex: 63% at the mid-range dose). Protection was related linearly to plasma concentration (plasma unbound NXY-059 concentration at 1 h: 37 ± 16 µmol l[sup -1] at the mid-range dose). 4 When the mid range dose was administered between 5 min-4 h after MCA occlusion, a marked and statistically significant protection was seen at all time points (44% protection in cortex at 4 h). 5 These data demonstrate the substantial neuroprotective efficacy of NXY-059 at plasma concentrations that can be achieved clinically and indicate that NXY-059 also has a therapeutic window of opportunity that is clinically relevant. [ABSTRACT FROM AUTHOR]
Titel: |
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
|
---|---|
Autor/in / Beteiligte Person: | Sydserff, S.G. ; Borelli, A.R. ; Green, A.R. ; Cross, A.J. |
Link: | |
Zeitschrift: | British Journal of Pharmacology, Jg. 135 (2002), Heft 1, S. 103-112 |
Veröffentlichung: | 2002 |
Medientyp: | academicJournal |
ISSN: | 0007-1188 (print) |
DOI: | 10.1038/sj.bjp.0704449 |
Schlagwort: |
|
Sonstiges: |
|